Novira Therapeutics Begins Phase 1a Clinical Study of NVR–1221 for the Treatment of Chronic Hepatitis B (HBV) Infection

By WebmasterMay 8, 2014November 1st, 2024No Comments

Novira Therapeutics Begins Phase 1a Clinical Study of NVR–1221 for the Treatment of Chronic Hepatitis B (HBV) Infection
Read more here

Previous PostGalleon's Sleep Apnea Pill Nears Human Tests
Next PostGalleon Pharmaceuticals Inc. Is Working On a More Simple Treatment for Sleep Apnea: A Pill